CD44 and cancer: Accordingly, metastasized CD44+ cancer stem cells in patient-derived xenograft mice were revealed to significantly upregulate WASF3 mRNA and, as previously mentioned, downregulate miR-93 in comparison to primary cancer stem cells [43].